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Introduction {#sec1}
============

Air pollution has been linked to the overall mortality in epidemiological investigations,[@bib1], [@bib2], [@bib3] and most pieces of evidence consider an increased cardiovascular disease incidence as a primary driver.[@bib4], [@bib5], [@bib6] The risk of adverse events seems to be increased in certain populations, including those with underlying health conditions, such as diabetes, chronic obstructive pulmonary disease, congestive heart failure, previous arrhythmia, and hypertension.[@bib7], [@bib8], [@bib9], [@bib10], [@bib11]

Implantable cardioverter-defibrillators (ICDs) are designed to detect/treat life-threatening ventricular arrhythmias. These devices are implanted under the skin and their electrodes are attached transvenously to the heart, where they monitor heart rhythm. On detecting a ventricular rate above a programmed value, they can initiate pacing and/or shock therapy to restore normal rhythm. The electrogram; beat-to-beat intervals immediately before, during, and after the event; and date/time of each event are recorded by the ICD and regularly downloaded during clinical follow-up. This feature makes an ICD a useful tool in investigating associations between acute air pollution exposures and incidence of ventricular arrhythmias.[@bib12]

Several studies have demonstrated associations between air pollution and ventricular arrhythmias in patients with ICD. However, the association between air pollution and near-term risk of ventricular arrhythmias in patients with ICD remains controversial. Some studies have shown an association,[@bib13], [@bib14] while other studies have found either no association[@bib15], [@bib16], [@bib17] or an association only for selected pollutants.[@bib18], [@bib19]

To our knowledge, a comprehensive and systematic meta-analysis of studies published in any language investigating the association between ambient air pollutants and ventricular arrhythmias in patients with ICD has not been performed. This report presents such a systematic review and meta-analysis.

Methods {#sec2}
=======

Search strategy {#sec2.1}
---------------

Databases including Medline, PubMed, Web of Science, Global Health Library, Virtual Health Library, Population Information Online (POPLINE), and New York Academy of Medicine Grey Literature Report, were searched using individual/combinations of the following keywords: "air pollutants" OR "air pollution" OR "environmental exposure" OR "particulate matter" OR "particles" OR "particle" OR "soot" OR "PM~10~" OR "PM(10)" OR"PM~2.5~" OR "PM(2.5)" OR "sulfur dioxide" OR "sulphur dioxide" OR "SO~2~" OR "SO(2)" OR "nitrogen dioxide" OR "nitrogen oxides" OR "NO~2~" OR "NO(2)" OR "carbon monoxide" OR "elemental carbon" OR "CO" OR "ozone" OR "O~3~" OR "O (3)" AND "implantable cardioverter-defibrillator" OR "ICD" AND "ventricular arrhythmia" OR "arrhythmia". Searches were limited to studies published from 1948 to June 31, 2017. The reference lists of the included studies and relevant reviews were also manually searched to identify remaining studies.

Inclusion and exclusion criteria {#sec2.2}
--------------------------------

The inclusion criteria were as follows: (1) study design: case-crossover and time series studies; (2) participants: patients with ICD; (3) ventricular arrhythmias detected in patients using ICD; (4) studies presenting original data for gaseous pollutants (i.e., CO, SO~2~, NO~2~, and O~3~) or particulate pollutants (i.e., PM~2.5~ or PM~10~); and (5) all studies that reported associations between ventricular arrhythmias and air pollutant concentrations lagged 0--7 days. Studies published in English were also included. The exclusion criteria were as follows: (1) animal experiments, case reports, commentaries, and multiple papers from the same study; (2) studies with no original data; and (3) for studies without enough quantitative data, the corresponding author was contacted, and if no answer was obtained, the studies were excluded.

Study selection {#sec2.3}
---------------

Two independent reviewers screened all abstracts and titles to identify potentially eligible studies. The full text was then screened to determine the final eligibility of the study for the review and meta-analysis. Disagreements regarding eligibility were resolved by a consensus with the help of a third reviewer.

Data extraction {#sec2.4}
---------------

Data extraction using a standardized form included a full description of the study characteristics (i.e., author, year of publication, location, type of study, age and sex of the population studied, outcome, follow-up duration, types of ventricular arrhythmias, air pollution exposure variables, and covariates included in the statistical models \[e.g., long-term time trend, season, temperature, humidity, pressure, day of the week, holidays, and influenza epidemics\]). The data from each study were extracted independently by two investigators using a unified data form. Conflicts were resolved by a consensus or through the help of a third investigator.

Quality assessment {#sec2.5}
------------------

There is no standardized scale assessing the methodological quality of this type of study. Therefore, the Newcastle-Ottawa Scale with some modifications was adapted to judge the study quality according to validated scales in previous studies and the Cochrane Collaboration.[@bib20], [@bib21] The three broad perspectives included the following: selection of the study population, comparability between groups, and assessment of the exposure or outcome. We evaluated seven items as follows: (1) representative of the study population; (2) description of the study methods; (3) assessment of the pollutants; (4) clearly defined ICD discharge ascertainment; (5) multiple lags; (6) adjustment of confounders; and (7) adequacy of follow-up length (to assess outcome). For the adjustment of confounders, 0 was given if no adjustment has been made for the temperature, time trends, and season; 1 was given if one item adjustment has been made; and 3 was given if all adjustments have been made. Studies scoring higher than 7 points were regarded as high-quality studies; studies scoring 4--6 points as good-quality studies; and studies scoring 3 points or below as low-quality studies.

Data synthesis {#sec2.6}
--------------

All pollutant concentrations were converted to μg/m^3^, if necessary, with the exception of CO, which was converted to mg/m^3^. Odds ratio (*OR*) was used as a measure of effect size because this is an intuitive and commonly used measure in the medical and public health literature. *ORs* were expressed for a standardized increase in pollutant concentration of 10 μg/m^3^, except for CO, which was expressed per 1 mg/m^3^ increase in concentration. When results were available from both the single-pollutant and multi-pollutant models, only the single-pollutant model results were included.

Different lag patterns were used in most of the included studies to evaluate immediate and delayed associations between pollutant exposure and ventricular arrhythmia risk in patients with ICD. Thus, a result was recorded into the database when only one lag time estimate was reported. When more than one was reported, the lag time was selected to include in the analysis based on the lag time that was the most statistically significant and the lag time with the largest effect estimate, either positive or negative.[@bib22]

Statistical analysis {#sec2.7}
--------------------

The results were presented as the incidence of outcome, *ORs*, 95% confidence intervals (*CIs*), and *P* values. Heterogeneity within studies was assessed using Cochran\'s *Q* and *I*^*2*^ statistics. *I*^*2*^ indicates the proportion of the total variance-explained heterogeneity, and higher values (0--100%) indicate greater heterogeneity. If the *P* value for heterogeneity was determined to be \<0.05 or the *I*^*2*^ value was \>50%, the presence of heterogeneity was taken into consideration. When heterogeneity was significant (*P* \< 0.05 or *I*^*2*^ \> 50%), the random-effects model was applied; otherwise, the fixed-effects model was used.[@bib23] Publication bias was evaluated through construction of funnel plots, Egger\'s regression test, and Begg\'s rank correlation method, in which *P* \< 0.05 was considered representative of a statistically significant publication bias. If a publication bias was found to be statistically significant, the trim and fill procedure was used to impute the number of potentially missing studies, and then the adjusted overall effect size was recomputed.[@bib24] Sensitivity analysis was also conducted to evaluate potential sources of heterogeneity for pollutants with a statistically significant heterogeneity. If the *P* value for heterogeneity was \<0.05, or the *I*^*2*^ value was \>50%, the meta-analysis was repeated after the removal of the studies with a high risk of bias.

Statistical significance was assigned at *P* \< 0.05. All tests were two-sided. All analyses were performed using the STATA version 12.0 (Stata Corporation, College Station, Texas, USA).

Results {#sec3}
=======

Search results and study characteristics {#sec3.1}
----------------------------------------

A total of 167 literature reports were initially identified. After screening the titles and abstracts, 47 full-text articles were assessed for eligibility, and seven were included in the analysis ([Fig. 1](#fig1){ref-type="fig"}). The detailed information from the seven publications (one time series study and six case-crossover studies) included in the meta-analysis is shown in [Table 1](#tbl1){ref-type="table"}. The number of pollutants considered by each study ranged from three to six. The data for these studies were drawn mainly from Medical Center or ICD clinics. Most of the study sites were in the United States or Europe. The number of events in each study ranged from 114 to 13,108; the mean patient age ranged from 53 to 65 years, and the majority of patients in each study were men (75--87%). The included studies had subject follow-up durations ranging from 0.8 to 10 years. As shown in [Table 2](#tbl2){ref-type="table"}, all studies scored 8 points or higher, suggesting that these studies were of high quality.Fig. 1Flow chart of the search strategy and selection of the studies for the meta-analysis.Fig. 1Table 1Characteristics of studies included in the meta-analysis.Table 1AuthorYearLocationStudy designNumber of patientsEvents (*n*)Male (%)Mean age (years)ICD dischargesFU (years)Air pollution exposure variablesPotential confounders includedRich et al[@bib15]2004CanadaCase-Crossover341288053N/C0.8PM~2.5~, PM~10~, CO, NO~2~, O~3~, SO~2~Trends, seasonality, temperature, humidity, Barometric pressure, holidaysMetzger et al[@bib16]2007U.SCase-Crossover51813,1087861VT9PM~2.5~, CO, NO~2~, O~3~, SO~2~Trends, seasonality, temperature, day of weekAnderson et al[@bib17]2010U.KCase-Crossover70554628765TAs10PM~2.5~, PM~10~, CO, NO~2~, O~3~, SO~2~Trends, temperature, holidaysPeters et al[@bib13]2000U.SCase-Crossover1002237962.2N/C3PM~2.5~, PM~10~, CO, NO~2~, O~3~, SO~2~Trends, seasonality, temperature, humidity, holidaysRich DQ et al[@bib18]2006U.SCase-Crossover56139NA63VAs1PM~2.5~, CO, NO~2~, O~3~, SO~2~Trends, Barometric pressure, temperature, humidity, days of weekDockery et al[@bib19]2005U.STime-series2039337564VT7PM~2.5~, CO, NO~2~, O~3~, SO~2~Trends, temperature humidity, day of weekLjungman et al[@bib14]2008SwedenCase-Crossover2111147962VAs5PM~2.5~, PM~10~, NO~2~Trends, Barometric pressure, temperature, humidity, days of week[^1]Table 2Quality assessment.Table 2StudyRepresentative of the study population (0--1 point)Description of study methods (0--1 point)Assessment of the pollutants (0--1 point)Clearly defined ICD discharged ascertainment (0--1 point)Multiple lags (0--1 point)Adjustment of confounders (0--3 points)Adequacy of follow up length (to assess outcome) (0--1 point)Total quality scoresRich et al[@bib15]11101318Metzger et al[@bib16]11111319Anderson et al[@bib17]11111218Peters et al[@bib13]11101318Rich DQ et al[@bib18]11111218Dockery et al[@bib19]11111218Ljungman et al[@bib14]11111218[^2]

Main air pollutants and ventricular arrhythmias in the patients with ICD {#sec3.2}
------------------------------------------------------------------------

The risk of ventricular arrhythmias in the patients with ICD was found to be positively, but not significantly, associated with CO, PM~10~, SO~2~, PM~2.5~, and NO~2~. The pooled estimates (*OR* associated with each 10 μg/m^3^ increase in pollutant concentration, except for CO, which was associated with each 1 mg/m^3^ increase in concentration) were 1.03 (95% *CI*: 0.92--1.17, *P* = 0.59) ([Fig. 2](#fig2){ref-type="fig"}) for CO, 1.01 (95% *CI*: 0.97--1.05, *P* = 0.55) ([Fig. 3](#fig3){ref-type="fig"}) for PM~10~, 1.09 (95% *CI*: 0.95--1.24, *P* = 0.23) ([Fig. 4](#fig4){ref-type="fig"}) for SO~2~, 1.07 (95% *CI*: 0.95--1.21, *P* = 0.25) ([Fig. 5](#fig5){ref-type="fig"}) for PM~2.5~, and 1.06 (95% *CI*: 0.98--1.14, *P* = 0.16) ([Fig. 6](#fig6){ref-type="fig"}) for NO~2~. No increased risk of ventricular arrhythmias in the patients with ICD was found to be associated with each 10 μg/m^3^ increase in the O~3~ concentration (*OR* = 1.00; 95% *CI*: 0.98--1.01, *P* = 0.56) ([Fig. 7](#fig7){ref-type="fig"}).Fig. 2Forest plot showing the association between CO and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator.Fig. 2Fig. 3Forest plot showing the association between PM~10~ and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator.Fig. 3Fig. 4Forest plot showing the association between SO~2~ and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator.Fig. 4Fig. 5Forest plot showing the association between PM~2.5~ and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator.Fig. 5Fig. 6Forest plot showing the association between NO~2~ and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator.Fig. 6Fig. 7Forest plot showing the association between O~3~ and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator.Fig. 7

Sensitivity analyses {#sec3.3}
--------------------

PM~2.5~ showed significant heterogeneity (*Q* test; *I*^*2*^ = 70.0%, *P* = 0.003), and sensitivity analyses were conducted to explore the source of heterogeneity. When the analyses were repeated after the removal of the time series study by Dockery et al,[@bib19] no significant heterogeneity across the studies was observed (*Q* test; *I*^*2*^ = 0.0%, *P* = 0.893). However, the effect was still not statistically significant (*OR* = 1.00, 95%*CI*: 0.95--1.06, *P* = 0.903) ([Fig. 8](#fig8){ref-type="fig"}). SO~2~ also showed significant heterogeneity (*Q* test; *I*^*2*^ = 56.8%, *P* = 0.041). In the sensitivity analyses for SO~2~, no significant heterogeneity across the studies was observed (*Q* test; *I*^*2*^ = 35%, *P* = 0.188) when the analyses were repeated after the removal of the study with large ICD discharge events (events \> 5462) by Metzger et al[@bib16]; however, the conclusion reversed into a statistically significant result (*OR* = 1.16, 95%*CI*: 1.04--1.31, *P* = 0.01) ([Fig. 9](#fig9){ref-type="fig"}), which means that the result was unstable.Fig. 8Sensitivity analyses of the association between PM~2.5~ and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator. Given named study is omitted.Fig. 8Fig. 9Sensitivity analyses of the association between SO~2~ and ventricular arrhythmia in the patients with implantable cardioverter-defibrillator. Given named study is omitted.Fig. 9

Publication bias {#sec3.4}
----------------

Publication bias was assessed by funnel plots, Egger\'s test, and Begg\'s test.

The symmetrical funnel plot indicated that there was no publication bias among studies. The results of the publication bias analyses are presented in [Table 3](#tbl3){ref-type="table"}. There was no evidence of publication bias for any of the air pollutants when assessed using the Begg\'s test or Egger\'s test.Table 3Publication bias across air pollutants.Table 3ItemBegg\'s regression testEgger\'s regression test*ZPtP*CO0.380.5730.750.562PM~10~0.730.4620.680.676SO~2~00.8510.990.584PM~2.5~1.050.2930.800.530NO~2~0.300.6520.560.151O~3~00.8510.120.188[^3]

Discussion {#sec4}
==========

The meta-analysis reported herein is the most comprehensive study that evaluated the associations between air pollution and ventricular arrhythmia in the patients with ICD. The risk of ventricular arrhythmias in the patients with ICD was positively, but not significantly, associated with CO, PM~10~, SO~2~, NO~2~, and PM~2.5~, but not associated with O~3~. A low heterogeneity across the studies was observed (except for PM~2.5~ and SO~2~), and no publication bias was observed in the sensitivity analyses.

According to previous studies, exposure to air pollution may cause fatal arrhythmias and sudden ventricular death. There are several mechanisms that may explain the association. The mechanisms of sudden ventricular death, precipitated by ventricular arrhythmias, have been described as a consequence of processes involving ischemic heart diseases, including congestive heart failure due to changes in inflammation and autonomic tone.[@bib25] First, increases in particulate air pollution have been linked to inflammation.[@bib26] The second hypothesis is that air pollution may affect blood coagulation, as studies have shown that particles can cross the pulmonary epithelium into the blood stream and cause thrombus formation, leading to additional or complete obstruction of the blood vessel (including coronary artery); this can eventually cause adverse cardiovascular events.[@bib27], [@bib28] The third hypothesis is that autonomic nervous system dysfunction may occur. Acute alterations in the sympathetic and parasympathetic tones and reduced heart rate variability are well documented in air pollution studies in humans[@bib29] and animals.[@bib30] Direct activation of the autonomic nervous system and the altered excitability of the heart cells caused by air pollution exposures may lead to fibrillation. Besides, an altered sympathetic or diminished parasympathetic tone of the heart in response to particle matter exposures might result in life-threatening arrhythmias, which would then cause discharge of ICDs. This mechanism may be the most plausible reason for our observed association. Overall, it was found that all air pollutants (except for O~3~) showed a positive association with ventricular arrhythmia in the patients with ICD. However, none of the air pollutants showed a statistically significant association.

As mentioned above, we selected the most frequently used short lags or the lags with the largest effect estimate from each study, reflecting short-term air pollutant exposure (i.e., over the past several days). Several studies found no associations between short-term increases in air pollutant concentrations and ventricular arrhythmias in patients with ICD[@bib13]^,^[@bib15]^,^[@bib31]. The lack of an effect in the patients with ICD may be due to the relatively low concentrations of air pollutants in the United States and Europe, relative to air pollutant concentrations in Asia.[@bib32] Thus, more studies are needed around the world.

Several important limitations exist in this meta-analysis. First, the levels of critical air pollutants (and thus the levels of individual exposures) differ among countries. PM~2.5~ and PM~10~ levels and exceedances of national and international standards were several times higher in some Asian countries, while levels in Europe and the United States were mostly well below the respective standards.[@bib33] However, as studies included in this meta-analysis were almost derived exclusively from the United States or Europe, this might bias the accuracy of the reported results and affect the robustness of the observed differences among regions. Another limitation of this analysis was that all cases of arrhythmias assessed in the meta-analysis were of the ventricular type. Although almost all ICD discharges recorded by ICD were ventricular arrhythmias (ventricular tachycardia and ventricular fibrillation), it is possible that a significant proportion of arrhythmias were supraventricular rather than ventricular, which could cause ICD discharges. Hence, the inclusion of only studies of ventricular arrhythmias may only allow us to conclude that the short-term increases in ambient air pollutant levels were associated with an increased risk of ventricular arrhythmias in ICD patients, but not all ventricular arrhythmias. Furthermore, the relationship between SO~2~ and ventricular arrhythmias in the patients with ICD was proven to be unstable, since it was remarkably influenced by the exclusion of the study by Metzger et al.[@bib16] In their study, the number of events of ICD discharge was more than 5462, which was higher than those in other studies; thus, the results should be interpreted with caution. Lastly, the methods used for lag selection in such air pollution meta-analyses remain controversial. In this meta-analysis, we almost selected the shortest lag, since the shortest lag time was reported to be the most statistically significant, in which the longer lags would be excluded; this may cause deviations in the results without taking long lags into consideration.

Conclusions {#sec5}
===========

To our knowledge, this meta-analysis is the first to evaluate the association between exposure to ambient air pollutants and risk of ventricular arrhythmias in the patients with ICD. Although the association was not statistically significant, this meta-analysis still provides some evidence that ambient air pollutants (except for O~3~) affect the risk of ICD discharges for treating ventricular arrhythmias.
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[^1]: ICD: implantable cardioverter-defibrillator; FU: follow-up; N/C: no classification; PM~2.5~: fine particulate matter; PM~10~: inhalable particles; CO: carbon monoxide; NO~2~: nitrogen dioxide; O~3~: ozone; SO~2~: sulfur dioxide; VT: ventricular tachyarrhythmias; TAs: tachyarrhythmias; NA: not applicable; VAs: ventricular arrhythmias.

[^2]: ICD: implantable cardioverter-defibrillator.

[^3]: CO: carbon monoxide; PM~10~: inhalable particles; SO~2~: sulfur dioxide; PM~2.5~: fine particulate matter; NO~2~: nitrogen dioxide; O~3~: ozone.
